SERPINE1 and neoplasm: uPA is modulated by the plasminogen activator inhibitor-1 (PAI-1), and combined assessment of uPA and PAI-1 was shown to be of value for prognostic determination [77, 78], indicating an impact of overall proteolytic balance on tumor progression.